Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth.
about
Surface architecture of histoplasma capsulatumEffect of anti-glycosphingolipid monoclonal antibodies in pathogenic fungal growth and differentiation. Characterization of monoclonal antibody MEST-3 directed to Manpalpha1-->3Manpalpha1-->2IPCPotential Roles of Fungal Extracellular Vesicles during InfectionTraveling into Outer Space: Unanswered Questions about Fungal Extracellular VesiclesNew insights on the development of fungal vaccines: from immunity to recent challengesExtracellular Vesicles: Role in Inflammatory Responses and Potential Uses in Vaccination in Cancer and Infectious DiseasesElucidating the immunological function of the Cryptococcus neoformans capsuleSurface localization of glucosylceramide during Cryptococcus neoformans infection allows targeting as a potential antifungalCharacterization of Scedosporium apiospermum glucosylceramides and their involvement in fungal development and macrophage functionsTransmembrane transporter expression regulated by the glucosylceramide pathway in Cryptococcus neoformans.Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan.Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism.Pathogen-specific antibodies: codependent no longerPassive immunization with melanin-binding monoclonal antibodies prolongs survival of mice with lethal Cryptococcus neoformans infectionStructural analysis of fungal cerebrosides.The plant defensin RsAFP2 induces cell wall stress, septin mislocalization and accumulation of ceramides in Candida albicans.Melanin from Fonsecaea pedrosoi induces production of human antifungal antibodies and enhances the antimicrobial efficacy of phagocytes.Role of sphingolipids in microbial pathogenesisLipidomic analysis of extracellular vesicles from the pathogenic phase of Paracoccidioides brasiliensis.Lipid rafts in Cryptococcus neoformans concentrate the virulence determinants phospholipase B1 and Cu/Zn superoxide dismutaseThe PbMDJ1 gene belongs to a conserved MDJ1/LON locus in thermodimorphic pathogenic fungi and encodes a heat shock protein that localizes to both the mitochondria and cell wall of Paracoccidioides brasiliensis.Structure, cellular distribution, antigenicity, and biological functions of Fonsecaea pedrosoi ceramide monohexosides.Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans.Characterization of cell wall lipids from the pathogenic phase of Paracoccidioides brasiliensis cultivated in the presence or absence of human plasma.A Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan.Synthesis and biological properties of fungal glucosylceramide.The contribution of melanin to microbial pathogenesis.Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport.Quality control of fungus-specific glucosylceramide in Cryptococcus neoformans by endoglycoceramidase-related protein 1 (EGCrP1)Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids.Methylation of glycosylated sphingolipid modulates membrane lipid topography and pathogenicity of Cryptococcus neoformans.Vesicle and vesicle-free extracellular proteome of Paracoccidioides brasiliensis: comparative analysis with other pathogenic fungi.Passive antibody therapy for infectious diseases.New concepts in antibody-mediated immunity.Glucosylceramide Administration as a Vaccination Strategy in Mouse Models of Cryptococcosis.Biosynthesis and immunogenicity of glucosylceramide in Cryptococcus neoformans and other human pathogens.Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Cryptococcus neoformans in immunodeficient miceCharacterization of Lipids and Proteins Associated to the Cell Wall of the Acapsular Mutant Cryptococcus neoformans Cap 67.Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum.The potential of antibody-mediated immunity in the defence against biological weapons.
P2860
Q21131150-C79268DC-372A-4E80-9388-ED1EB13D2337Q24633865-D12B312B-4B4A-4789-A527-5D4108C9B000Q26743448-5ED90791-6159-4865-858B-E09DA40D7C98Q26775138-1538866C-2A0A-49BA-9213-E5EBD1E488C4Q26776056-0964CF5C-C37E-400E-81BA-993E730B40CBQ26783960-EB9D1B02-CD3F-4C57-9EC7-F8D73275E938Q26859234-B3DADF72-24EF-435D-B564-8F4FCA7EB24AQ28476796-730A3A0F-9A0A-40DD-BC23-AA09CBFCF2E9Q28539197-42085024-4AE2-4BFA-A6EE-E07C18B04266Q30278081-EED74467-56E9-4C64-83E0-10F40D5B489DQ30481655-BA7D6C73-6C96-4482-8B12-31BCD3E0D0C6Q33755308-08CB7828-CCDA-4A72-9DB7-241A6A2AC509Q33755471-F11B64E3-26DC-4E7F-A1E3-AF1624E142A6Q34007418-C94D5363-B474-4360-A6E4-64193AD78892Q34098854-901DDB94-6C4A-413C-BFFB-A8E6D41C6582Q34183105-BD53274A-DE14-42BF-A31F-49F6BE854D23Q34285375-FC462309-C61E-4DFB-A0D2-49BCA81C91E5Q34300991-0BDB93D2-5754-456A-977F-D317AE4A0AA1Q34321418-FCECD716-88BF-4AF0-B598-CC63226F9293Q34442091-9FF92B39-E19E-41FE-AD37-B27116A2E602Q34461673-45A01860-D2BB-480A-91DC-47902C46E040Q34469047-1FC86E7E-954F-474E-901A-458A0B645CC8Q34628045-D4CDCD9A-6260-45A1-B020-5415938719D8Q34730375-BED67592-D9B7-486D-B12C-B478E9BCEA02Q34907746-2CA52DA2-EED6-4E96-9EE6-6DC82D0FE033Q35084966-79A900FF-6C25-492C-B2E2-37758AC835ADQ35098810-5E9F4D42-4984-4899-9B78-94EAEE88BF5CQ35641043-1744B43E-6934-449A-AB1C-EE8C8466E3F5Q35643688-759743CC-6507-44E0-89FB-F0AA4955FA18Q35672458-90773A48-5139-4A30-898B-39294217B4D7Q35827998-85D61327-606C-46EC-BD60-6873CAE2CDD9Q35869182-C0DE18ED-12BE-481D-A574-A2E665B8D593Q35889582-23D5AEA8-E6D9-4088-94A9-85DF9EB94A15Q35926507-6FFB219E-6DA9-4532-A149-E7A1974E1BD8Q35991081-7FBAF199-7F73-4518-8D1D-23A914CBE44CQ36095320-E84F3C73-C539-4501-B8CE-57D35A53682EQ36097293-312B41DF-AF7F-49A5-A2D4-B83E1E513495Q36208572-077131B4-FD06-4BAD-A192-C5150A4B0F6AQ36259740-F02D3BAF-7310-4131-9CEE-168A7AC7739CQ36273411-0F50CE0B-AE2A-4E19-A8D4-210FD8599983
P2860
Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Human antibodies against a pur ...... ell budding and fungal growth.
@en
Human antibodies against a pur ...... ell budding and fungal growth.
@nl
type
label
Human antibodies against a pur ...... ell budding and fungal growth.
@en
Human antibodies against a pur ...... ell budding and fungal growth.
@nl
prefLabel
Human antibodies against a pur ...... ell budding and fungal growth.
@en
Human antibodies against a pur ...... ell budding and fungal growth.
@nl
P2093
P2860
P1476
Human antibodies against a pur ...... ell budding and fungal growth.
@en
P2093
A J Franzen
C S Alviano
E Barreto-Bergter
K R Miranda
L R Travassos
M L Rodrigues
S Rozental
W de Souza
P2860
P304
P356
10.1128/IAI.68.12.7049-7060.2000
P407
P577
2000-12-01T00:00:00Z